Jyong Biotech Ltd. Ordinary Shares

Jyong Biotech Ltd. Ordinary Shares

MENS - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$107.64M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Jyong Biotech Ltd. Ordinary SharesJyong Biotech Ltd. Ordinary Shares-20.3-19%--0.7
$-0.24

Current Fair Value

116.4% downside

Overvalued by 116.4% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$107.64 Million
Enterprise Value$125.01 Million
Earnings per Share$-0.06
Beta2.52
Outstanding Shares74,233,667

Return

Return on Equity18.76%ROE
Return on Assets-22.49%
Return on Invested Capital18.72%

Valuation & Multiples

P/E Ratio-20.35P/E Ratio
PEG-0.01PEG
Price to Sales-Price to Sales
Price to Book Ratio-1.45Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-47.58
Enterprise Value to Net Income-27
Total Debt to Enterprise0.15
Debt to Equity-0.74Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 19, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.60%▼ 0.07%
Total Invested$903,892▼ 10.56%
Investors Holding17▼ 2.00%

About Jyong Biotech Ltd. Ordinary Shares

27 employees
CEO: Fu-Feng Kuo

Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the research, development, and market introduction of botanical therapeutics, specifically aimed at addressing diseases of the urinary system. Its operations are orc...

Questions & Answers